Dasatrue 70mg Tablet

PRODUCT INTRODUCTION

Dasatrue 70mg Tablet is a medication belonging to the class of drugs known as “proteasome inhibitors.” It contains the active ingredient Dasatinib, which is primarily used in the treatment of certain types of cancer, specifically chronic myeloid leukemia (CML) and acute lymphoblastic leukemia (ALL). Dasatinib works by blocking certain proteins in cancer cells, thereby inhibiting their growth and proliferation. It is available in the form of oral tablets and is typically prescribed by oncologists or hematologists for patients diagnosed with the aforementioned conditions.

USES OF Dasatrue 70mg Tablet

Dasatrue 70mg Tablet is primarily prescribed for the following medical conditions:

• Chronic Myeloid Leukemia (CML): It is indicated for the treatment of adults and children diagnosed with chronic phase, accelerated phase, or blast phase CML who are resistant to or intolerant of prior therapy, including imatinib.
• Acute Lymphoblastic Leukemia (ALL): It may be used in combination with other medications for the treatment of Philadelphia chromosome-positive (Ph+) ALL in adults who have not responded to previous treatments.

BENEFITS OF Dasatrue 70mg Tablet

The benefits of Dasatrue 70mg Tablet include:

• Effective Treatment: Dasatinib has shown significant efficacy in the treatment of chronic myeloid leukemia and acute lymphoblastic leukemia, particularly in patients who have developed resistance to other therapies.
• Prolonged Survival: Clinical studies have demonstrated that Dasatinib treatment can lead to prolonged survival rates in patients with CML and ALL.
• Improved Quality of Life: By effectively controlling the progression of leukemia, Dasatinib can help improve the quality of life for patients by alleviating symptoms and reducing the need for hospitalization.

SIDE EFFECTS OF Dasatrue 70mg Tablet

While Dasatrue 70mg Tablet is generally well-tolerated, like any medication, it may cause certain side effects. Common side effects associated with Dasatinib treatment may include:

• Gastrointestinal Disturbances: Nausea, vomiting, diarrhea, and abdominal pain are common gastrointestinal side effects. These symptoms are usually mild to moderate and can often be managed with supportive care or adjustments in diet.
• Fatigue: Patients may experience fatigue or weakness, which can affect daily activities. Adequate rest and activity management are recommended to alleviate these symptoms.
• Headache: Some individuals may experience headaches while taking Dasatinib. It is advisable to inform a healthcare provider if headaches are severe or persistent.
• Skin Reactions: Rash, itching, and dry skin are potential dermatological side effects. Proper skincare and hydration can help alleviate these symptoms.
• Hematological Effects: Dasatinib may cause changes in blood cell counts, including low white blood cell counts (neutropenia), low platelet counts (thrombocytopenia), or anemia. Regular blood tests are necessary to monitor for these effects, and dose adjustments may be required.
• Cardiovascular Effects: In some cases, Dasatinib treatment may lead to fluid retention, high blood pressure, or an irregular heartbeat (arrhythmia). Patients with pre-existing cardiovascular conditions should be closely monitored during treatment.

References